The chemical substance known as (16R)-7,16-dimethyl-6,8,9,16-tetrahydrobis[1,3]benzodioxolo[4,5-c:5',6'-g]azecin-15(7H)-one, with the CAS number 521-85-7, is a complex organic compound characterized by its unique bicyclic structure that incorporates multiple fused rings and functional groups. This compound features a tetrahydroazecine core, which is further substituted with methyl groups and benzodioxole moieties, contributing to its intricate three-dimensional conformation. The presence of these structural elements often imparts specific biological activities, making such compounds of interest in medicinal chemistry and pharmacology. The stereochemistry, indicated by the (16R) designation, suggests a specific spatial arrangement of atoms that can significantly influence the compound's reactivity and interaction with biological targets. Additionally, the compound's solubility, stability, and potential applications in drug development are influenced by its molecular structure. Overall, this substance exemplifies the complexity and diversity found in organic chemistry, particularly in the realm of natural product derivatives and synthetic analogs.

(16R)-7,16-dimethyl-6,8,9,16-tetrahydrobis[1,3]benzodioxolo[4,5-c:5',6'-g]azecin-15(7H)-one

521-85-7: 521-85-7, Corycavamine, Corycavine

Corycavine is an alkaloid compound, which is derived from certain species of Corydalis plants, particularly from their roots. This naturally occurring substance acts primarily as an alpha-adrenoceptor antagonist, modulating adrenergic signaling pathways. By competitively inhibiting the binding of endogenous catecholamines such as norepinephrine, it influences vascular tone and other physiological processes mediated by alpha-adrenergic receptors.

Corycavine is employed in pharmacological research to understand alpha-adrenergic receptor functions and to explore potential therapeutic avenues for conditions like hypertension, where modulation of vascular resistance is crucial. Its role in experimental settings allows scientists to dissect adrenergic mechanisms and develop novel therapeutic strategies. Understanding the pharmacokinetics and specific interactions of Corycavine with cellular targets is vital for elucidating its impact within biological systems, potentially guiding the development of future adrenergic modulators.

CAS 521-85-7: (16R)-7,16-dimethyl-6,8,9,16-tetrahydrobis[1,3]benzodioxolo[4,5-c:5',6'-g]azecin-15(7H)-one

Corycavine

Ref: 3D-FC65473